Yes, and this is common practice in the preclinical literature
Second, GLP-1 agonists appear to dampen the dopaminergic response to alcohol, which means patients sometimes drink less (good) but also sometimes feel the effects of alcohol harder than expected (caution)
now she actively schedules meals so she doesnt forget to eat at regular intervals
Although HCQ and CQ are generally well tolerated, updated 2016 guidelines recommend that the maximum daily dose should not exceed 5 mg/kg of actual body weight, as excessive dosing and long-term therapy are considered major risk factors for retinal toxicity (Marmor et al., 2016)
Weight loss is a common and welcomed side effect for many patients
However, when combined with other glucose-lowering medicationsparticularly sulfonylureas (e.g., gliclazide) or insulinthe risk of hypoglycaemia increases substantially